相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cutaneous Adverse Events to Type I BRAF Inhibitors: An Analysis of Effects Associated with Each Inhibitor and Therapeutic Time Interval to Onset
Dan C. Filitis et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2013)
Antitumor Activity of the Selective Pan-RAF Inhibitor TAK-632 in BRAF Inhibitor-Resistant Melanoma
Akito Nakamura et al.
CANCER RESEARCH (2013)
BRAF Inhibitor-Driven Tumor Proliferation in a KRAS-Mutated Colon Carcinoma Is Not Overcome by MEK1/2 Inhibition
Miles C. Andrews et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Cutaneous toxicities of RAF inhibitors
Rachael Anforth et al.
LANCET ONCOLOGY (2013)
Paradoxical oncogenesis-the long-term effects of BRAF inhibition in melanoma
Geoffrey T. Gibney et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
Discovery of a Novel ERK Inhibitor with Activity in Models of Acquired Resistance to BRAF and MEK Inhibitors
Erick J. Morris et al.
CANCER DISCOVERY (2013)
Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
Axel Hauschild et al.
LANCET (2012)
Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations
Keith T. Flaherty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma
Keith T. Flaherty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
RAS Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors
Fei Su et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Genome-wide association studies in melanoma: off to a good start
Hye Kyung Kim et al.
PIGMENT CELL & MELANOMA RESEARCH (2012)
Prognostic and Clinicopathologic Associations of Oncogenic BRAF in Metastatic Melanoma
Georgina V. Long et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Paul B. Chapman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Mutations of the BRAF gene in human cancer
H Davies et al.
NATURE (2002)
分享论文
